OnabotulinumtoxinA Dosing, Disease Severity, and Treatment Benefit in Patients With Cervical Dystonia: A Cohort Analysis From CD PROBE

INTRODUCTION: The Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy (CD PROBE) study (ClinicalTrials.gov identifier: NCT00836017), a multicenter, prospective, observational registry, was designed to identify real-world practices and outcomes for patients with cervical...

Descripción completa

Detalles Bibliográficos
Autores principales: Agarwal, Pinky, Barbano, Richard, Moore, Henry, Schwartz, Marc, Zuzek, Aleksej, Sadeghi, Marjan, Patel, Atul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281448/
https://www.ncbi.nlm.nih.gov/pubmed/35847221
http://dx.doi.org/10.3389/fneur.2022.914486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9281448/
https://www.ncbi.nlm.nih.gov/pubmed/35847221
http://dx.doi.org/10.3389/fneur.2022.914486

Ejemplares similares